Primary hyperparathyroidism is a frequent and potentially debilitating endocrine disorder for which surgery is the only curative treatment. The modalities of parathyroid surgery have changed over the last two decades, as conventional bilateral neck exploration is no longer the only surgical approach. Parathyroid scintigraphy plays a major role to define the surgical strategy, given its ability to orient a targeted (focused) parathyroidectomy and to recognize ectopic locations or multiglandular disease.
Primary hyperparathyroidism (PHPT) is the third most common endocrine disorder after diabetes and hyperthyroidism (1) . The prevalence in women over 50 is about 2% (2) . The diagnosis is often done in asymptomatic subjects during a routine serum calcium measurement (1, 3) . PHPT classically associates elevated total serum calcium (after adjustment for albumin concentration) and elevated serum PTH level. However, in some patients PTH levels may be normal but inappropriate to hypercalcemia. Patients with vitamin D insufficiency may have higher PTH levels and thus 25(OH)D should be measured. One important differential diagnosis, because surgery is not warranted, is familial hypocalciuric hypercalcemia, which is due to heterozygous calcium-sensing receptor gene (CaSR) mutations and is associated with low urinary calcium.
The clinical signs and symptoms that are often associated with symptomatic PHPT involve the skeleton (osteoporotic fractures, pain, bone lesions, chondrocalcinosis), the kidneys (nephrolithiasis, nephrocalcinosis, impaired renal function) and, more rarely nowadays, the digestive tract (peptic ulcers, constipation, pancreatitis) and the cardiovascular system (hypertension) (1) (2) (3) (4) . PHPT may also cause neuropsychiatric symptoms, cognitive impairments and decreased quality of life. Hypercalcemic crisis is rare but is a life-threatening medical emergency.
Patients with asymptomatic PHPT may remain stable over many years or show progression. After 15 years of prospective follow-up, about one third of subjects develop additional signs of the disease (e.g., kidney stones, worsening hypercalcemia, reduced bone mineral density or fragility fractures) (3) .
Surgery is the only curative treatment for PHPT. According to recent recommendations (4), surgery is indicated in any patient younger than 50, any symptomatic patient, and in asymptomatic patients with any of the following parameters at diagnosis or during follow-up: serum calcium >0.25 mmol/L (>1 mg/dL) above the upper limit of normal; a calculated creatinine clearance <60ml/min; a 24h-urine calcium >10 mmol (>400mg) and increased stone risk; nephrolithiasis or nephrocalcinosis on imaging (X-ray, ultrasound or CT); osteoporosis (T score of -2.5 or lower at lumbar spine, total hip, femoral neck, or distal 1/3 radius, measured by dual-energy X-ray absorptiometry), or vertebral fracture on imaging studies.
Although a single parathyroid adenoma is the most frequent occurrence, multiglandular disease (MGD) with two, sometimes three, adenomas or a multiglandular hyperplasia is present by on November 7, 2017. For personal use only. jnm.snmjournals.org Downloaded from 4 in 15-20% of cases (1, 5) . Parathyroid carcinoma is rare (<1% of cases of PHPT) and is associated with a ten-year recurrence-free and disease-specific survival of 69% and 91%, respectively (6) .
MGD can be either sporadic or hereditary, such as in isolated familial PHPT or in MEN 1 (menin gene MEN1 mutation), MEN 2A (RET oncogene mutation), MEN 4 (CDKN1B mutation) and hyperparathyroidism-jaw tumor (HRPT2/CDC73 mutation; risk of parathyroid carcinoma) syndromes (7) . MEN 2B (also called MEN-3) is rarely associated with PHPT. Parathyroid involvement is observed in 95% of MEN1 cases and is most often the initial manifestation. A correct diagnosis of MEN1 is important for performing adequate initial surgery and for early detection of other associated endocrinopathies (pancreaticoduodenal, pituitary, or thymic tumors and occasional bronchial carcinoids) (7, 8) . It must be suspected in case of MGD or in case of PHPT in subjects younger than 30. Long-term treatment with lithium or a history of neck radiation is also associated with MGD.
About 10 to 15% of normal subjects harbor a "fifth parathyroid gland" (9) .
Supernumerary glands can cause recurrent disease (e.g., in MEN1).
Conventional surgery for PHPT relies on the inspection of the four parathyroid glands through bilateral cervical exploration (5) . In recent years, there has been a significant shift towards targeted operations (10), which may be performed during open surgery (7, 10) , or by endoscopic approaches (11) . This shift has been driven by two technological developments: more sensitive imaging techniques, which enabled the preoperatory detection of the lesions, and intraoperative PTH monitoring, to verify the absence of other hyperactive glands (12) .
Proposed by the team of O'Doherty and Coakley (13), 99m Tc-MIBI scintigraphy rapidly gained widespread acceptance and rendered thallium-201 parathyroid scan obsolete. It was recognized as the most sensitive noninvasive imaging study in PHPT (14) (15) (16) . Parathyroid ultrasound is often used as a complementary imaging technique, although its effectiveness depends on operator's skills (10). As stated in the EANM and SNMMI parathyroid guidelines, imaging is optional before bilateral surgery of PHPT, but is strongly recommended before targeted surgery or in case of re-intervention (17, 18) . Surgery of hyperparathyroidism secondary to renal failure is not discussed here. In these patients, preoperative scintigraphy can help select the least autonomous parathyroid tissue for preservation and identify ectopic or supernumerary parathyroid glands (19) (20) (21) which are the main cause of recurrent disease (22).
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This review article addresses some key points related to imaging of PHPT. It is the product of collaboration between nuclear physicians, endocrinologist and endocrine surgeons and complies with ethical guidelines of the authors' institutions.
USEFULNESS OF PREOPERATIVE IMAGING PRIOR TO CONVENTIONAL BILATERAL SURGERY
Without imaging, bilateral cervical exploration is curative in 92-95% of patients operated for PHPT, as shown by older studies done before modern imaging was available (5) . Indeed, an experienced surgeon can identify the majority of pathological glands (9, (23) (24) (25) .
However, preoperative imaging allows selecting patients eligible for targeted surgery and identifying ectopic glands. The incidence of ectopic glands is estimated at 6 to 16% (24). The majority of ectopic glands present a minor ectopia (e.g. in thyrothymic ligaments, tracheoesophageal groove or partially embedded in the thyroid) and are easily located by an experienced surgeon. However, some parathyroid glands present major ectopia, which might lead to surgery failure, even for experienced surgeons, and can be a source of medical litigation. For example, 1 to 2% of subjects have ectopic glands that require thoracic surgery instead of cervical surgery (23, 24).
In agreement with recent recommendation (16), we think that preoperative imaging should always be performed. Good imaging should be effective, provide morphological and functional information, be non-invasive and not too expensive. These conditions can be fulfilled by combining cervical ultrasound and scintigraphy. In a retrospective series of 202 resected ectopic glands (major and minor ectopias), preoperative scintigraphy had a sensitivity of 89% and a positive predictive value of 90%. Among 59 patients who underwent both scintigraphy and ultrasound, scintigraphy was superior to ultrasound in 28 patients and inferior in 3 (27). Ultrasound detection is hampered in case of retrotracheal/retroesophageal or intrathoracic parathyroid gland.
Positive parathyroid scans
Ectopias can be acquired or congenital. Tumors from superior parathyroid glands (also named P4) might prolapse along the tracheo-esophageal groove into the lower neck or upper mediastinum, and can be found in para-or retro-esophageal position. By contrast, ectopias of the lower parathyroids (P3) are often congenital due to an abnormal migration of the glands. They may be located close to carotid and jugular vessels in the neck or inside the thymus in the anterior mediastinum. More rarely, pathological glands can be associated with the vagal nerve within the carotid sheath, or in the aorto-pulmonary window. Parathyroid glands completely buried in the thyroid parenchyma may be derived from P3, P4 or be supernumerary glands.
Suspecting a MGD on preoperative imaging may help the surgeon planning the surgical approach.
Finally, although thyroid nodules might be a cause of false positives on parathyroid scintigraphy, it should not be forgotten that a MIBI-positive, iodine-negative thyroid nodule is suspect of malignancy (28) and might justify fine-needle biopsy before parathyroid surgery.
Negative parathyroid scans
In principle, imaging results should not influence the surgical decision (12, 29) . However, some recent studies (30-32), although not all (33), reported that surgical failure rate is higher when preoperative imaging studies are negative.
According to a multicentric study, patients with negative ultrasound and scintigraphy had smaller parathyroid lesions and a higher proportion of hyperplasia (22%). Moreover, cervicotomy involved a higher number of extended surgical procedures, such as thyroidectomy and thymectomy. Finally, PHPT was still present in 18% of subjects after surgery (30). Even in a center of great experience as the Mayo Clinic, the surgical failure rate in scintigraphy-negative patients can be as high as 10%, despite the use of intraoperative PTH assay (31).
by on November 7, 2017. For personal use only. jnm.snmjournals.org Downloaded from Thus, a negative imaging is also informative and indicates that an experienced multidisciplinary team, including a surgeon, an endocrinologist, and imaging specialists should be entrusted with the case.
ADVANTAGES AND DRAWBACKS OF TARGETED SURGERY
Targeted parathyroidectomy entails several advantages: a lower rate of complications, such as hypoparathyroidism, nerve injury, or unaesthetic scars, a shorter operation time, and a higher possibility of outpatient surgery and local anesthesia.
The option of targeted surgery should however be entertained only if the rate of failure (e.g. unrecognized MGD) is acceptably low. A Swedish randomized study (34) showed an advantage for unilateral surgery, in terms of operative time and incidence of transient hypocalcemia, while the rate of failure (persistent or recurrent hyperparathyroidism) was not significantly higher (8.5% for unilateral surgery vs. 4.5% for bilateral surgery). However, a potential bias to these comparisons is that patients randomized for bilateral surgery did not undergo scintigraphy (26).
In order to reduce the risk of failure, several institutions associate targeted surgery with intraoperative PTH monitoring (7) . PTH has a short half-life in plasma (2 to 4 minutes).
According to the widely used Miami criterion (35), a 50% decrease in PTH levels 10 minutes after removal of the putative lesion suggests a curative surgery. However, the procedure might sometimes yield inaccurate results, as when PTH concentrations decrease even in presence of a second smaller lesion (36, 37). The prevalence of MGD, estimated on the basis of intraoperative PTH monitoring, is about 5% (35), much lower than the conventional rate of 15-20% (5, 38).
Intraoperative PTH monitoring might also wrongly lead to bilateral surgery, due to delayed decay of PTH in case of excessive mobilization of the adenoma before its removal or slow elimination kinetics in some patients.
Although recommended when performing targeted parathyroidectomy (7), rapid PTH assays is not available to most surgeons worldwide (7) . Moreover, PTH monitoring prolongs operation time and limits the feasibility of local anesthesia. As an alternative to intraoperative by on November 7, 2017. For personal use only. jnm.snmjournals.org Downloaded from PTH, some surgeons recommend inspection of the ipsilateral gland (39). In case of doubleadenomas, however, bilateral distribution is expected, not only because of probability (two thirds of the cases), but also because they often originate from the two superior glands (40).
Another point to consider is that targeted surgery might require conversion to bilateral surgery in about 20% of cases (41, 42). Conversion is often due to imaging failure: wrong localization, multi-glandular disease missed by imaging and identified by inspection of the ipsilateral gland or intraoperative PTH monitoring (41).
In summary, as stated in the SNMMI and EANM guidelines, a good preoperative imaging study can play a major role in the selection of candidates for targeted surgery (17, 18) .
PERFORMANCE OF DIFFERENT SCINTIGRAPHIC PROTOCOLS TO GUIDE TARGETED SURGERY
A valuable pre-surgical imaging technique should be able to 1) identify MGD, 2) limit the Ultrasound is not accurate enough to be used alone for targeted surgery. It has low sensitivity for MGD or ectopic lesions. In the study by Haber and colleagues (44), ultrasound recognized only 17% of MGD cases (1/6) and 25% of ectopic glands (2/8).
Although a meta-analysis showed that scintigraphy is superior to ultrasound, its sensitivity decreases in case of MGD (88.44% for single adenoma, 44.46% for hyperplasia; 29.95% for dual adenoma). Moreover, sensitivity varies greatly among different studies (15) . Description of the single-tracer "dual-phase" and dual-tracer "subtraction" parathyroid scintigraphy protocols can be found in the SNMMI and EANM guidelines (17, 18) . A summary of the techniques is also provided in Table- Tc-MIBI scan, is likely to be a solitary adenoma (48). However, because MGD is rarely seen on late scintigraphic images (17, 46) , this approach has been recently abandoned by the very team who first proposed it (49).
Importance of Simultaneous Dual-Tracer Imaging
Hindié and colleagues proposed a (Fig-1) . The advantages of dual-isotope subtraction scintigraphy have been highlighted by several recent studies (51-54). In a comparative analysis on 37 patients (41 lesions), Caveny and colleagues confirmed the superiority of the simultaneous dual-tracer technique over the single-tracer "double-phase" protocol both in terms of sensitivity (94% vs. Simultaneous dual-isotope acquisition has high sensitivity for the identification of MGD (55) (Fig-2) . Careful image analysis is nevertheless required because MGD is commonly
characterized by the presence of glands of unequal size and unequal intensity of tracer uptake (55). Thus, a pinhole view is necessary for optimal sensitivity (17, 53, 54 60% (56, 57) . In fact, the use of 99m Tc-pertechnetate precludes the acquisition of a simultaneous image and the subtraction image may thus suffer from motion artifacts.
Moreover, dual isotope SPECT/CT acquisition would not be possible.
Dual-tracer imaging should be performed at least three weeks after radiologic examinations involving iodine contrast media administration. Also, thyroid hormone replacement therapy should be withheld for two weeks before imaging. This is necessary even in case of previous thyroidectomy as 123 I would allow the correct identification of residual thyroid tissue, which can be mistaken for an enlarged parathyroid on 99m
Tc-MIBI single-tracer scintigraphy or at neck ultrasound (Fig-3) .
The Role of Dual Isotope SPECT/CT
Tomographic imaging of parathyroids (SPECT or SPECT/CT) is less sensitive than, and therefore cannot replace, pinhole imaging, especially because the shoulders stand in the field of view (58) . In a prospective study by Neumann and colleagues, subtraction SPECT/CT had an overall sensitivity of 70% (59) . The subtraction of dual-isotope tomographic images is more complex than with pinhole planar images. In our clinical practice, we prefer to compare visually the three tomographic projections of 99m Tc-MIBI and 123 I images, without subtraction. We perform subtraction only on the pinhole images (Fig-2) .
However, complementary SPECT/CT provides useful information (59, 60) , such as the correct anatomical localization of a lesion on the anteroposterior axis. For instance, posterior adenomas are preferably resected through a lateral approach. When SPECT/CT machines were not available, this information was less accurately obtained through anterior oblique or lateral pinhole views. Lateral views, and now SPECT/CT, can also help differentiate thyroid from parathyroid foci, or identify a parathyroid lesion situated behind a thyroid nodule or behind another parathyroid lesion (51, 55, 58).
Finally, SPECT/CT is very useful for ectopic parathyroid lesions and to differentiate pathological from physiological foci of uptake (e.g., brown fat, muscle, bone marrow).
Multiphase "4D-CT" Scanner
Some reports suggest superiority of 4D-CT compared to scintigraphy and recommend it as an initial localization study in PHPT (61) . Despite its sophisticated images, it is still controversial whether 4D-CT scanner can reliably identify MGD or differentiate thyroid nodules from parathyroid lesions. Especially since, in the existing studies, 4D-CT was not compared to subtraction scintigraphy. Sensitivity of 4D-CT in diagnosing MGD was only 32% in the study by Kukar (61) and 14% in the study by Madorin (62) . Because 4D-CT scanner uses a 3-or a 4-phase CT protocol, it delivers a high dose to the thyroid, which is problematic in younger patients (62), and needs the injection of contrast medium in a population where renal impairment is not uncommon.
IMAGING STRATEGY BEFORE REOPERATION FOR PERSISTENT OR RECURRENT HYPERPARATHYROIDISM
Reoperation should be decided carefully, as the complication rate is higher than for a first surgery, even for experienced teams (63) . Accurate preoperative localization is therefore essential.
First-line imaging should include both scintigraphy and neck ultrasound. Concordant localization by two modalities is required. In case of a cervical image of uncertain origin, ultrasound-guided fine needle aspiration for PTH assay may be performed (16 Tc-MIBI scintigraphy (double-phase planar imaging + SPECT) was 33% (6/18) and the positive predictive value 67% (6/9). This translated into a low cure rate (11/19 patients) (67) . Again, the sensitivity of dual-tracer scintigraphy in patients with persistent hyperparathyroidism seems to be quite higher than that of single-tracer scintigraphy, as shown in a prospective study by Schalin-Jantti and colleagues comparing different techniques for the localization of parathyroid glands (68) . 
PARATHYROID IMAGING WITH NOVEL PET TRACERS
11 C-methionine seems to be a sensitive tracer to image patients before re-operation (65, 68, 69) . In the study by Schalin-Jantti, the sensitivity of 11 C-methionine PET was comparable to that of subtraction scintigraphy (65% vs. 59%) but with one false positive (68) . In another series that investigated patients with previous neck surgery and negative single-tracer had MGD). 18 F-fluorocholine images were better defined at 60min than at 5min (better lesion-tobackground and lesion-to-thyroid contrast). A potential advantage of 18 F-fluorocholine imaging is the higher resolution associated with PET technology (Fig-4) and the shorter imaging time. Potential drawbacks are the higher cost and the absence of a specific thyroid tracer, with risk of false-positive from thyroid nodules but also from inflammatory lymph-nodes. Intravenous contrast medium administration during choline PET/CT imaging might further improve results, especially in case of recurrent disease. 
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